PO.TB10.08 · 肿瘤生物学
空间组织结构作为成人胶质瘤肿瘤和微环境状态的统一原则
Spatial tissue architecture as a unifying principle of tumor and microenvironmental states in adult gliomas
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
成人胶质瘤表现出显著的分子和病理变异。既往的单细胞研究已表征了瘤内异质性;在胶质母细胞瘤中,肿瘤细胞采用谱系相关程序——例如少突胶质细胞和神经元祖细胞(OPC、NPC)、星形胶质细胞(AC)和间充质(MES)样状态。然而,这些状态如何在其他胶质瘤中重现仍不清楚。鉴于它们共享的环境,界定保守的与实体特异性的肿瘤特征对于理解胶质瘤异质性至关重要。
在此,我们使用单细胞空间转录组学(344基因panel,10x Xenium),分析了来自284例患者、涵盖少突胶质细胞瘤、星形细胞瘤、胶质母细胞瘤和室管膜瘤的310个肿瘤核心。该方法产生了一个包含280万个细胞的数据集,其中包括18种肿瘤微环境(TME)细胞类型。为进一步探究局部相互作用,我们使用5,096基因panel和多重免疫荧光(57种蛋白)对一个星形细胞瘤验证队列进行了分析。
我们的数据揭示了跨胶质瘤的9种复发性肿瘤状态,它们组织成由局部细胞相互作用塑造的邻域。这些形成了结构化的层次,OPC/NPC样肿瘤位于皮质界面附近,而AC样区域与MES1-胶质增生形成连续体。邻域在很大程度上是亚型特异性的,提示是组织结构而不仅仅是细胞组成构成了胶质瘤异质性的基础。与此一致,甲基化分类——在胶质瘤亚型定义中处于核心地位——将该队列分层为13类,具有不同的邻域特征,包括RTK1、RTK2和MES胶质母细胞瘤中的特征性结构。
邻域还表现出不同的TME变异:P2RY12⁺小胶质细胞在AC样和MES1-胶质增生区域富集,而CD163⁺髓系细胞则集中在MES1-胶质增生和MES2-缺氧微龛。这些免疫模式与邻域特异性炎症程序相对应,并在实体层面对应于室管膜瘤中以髓系为主的炎症和少突胶质细胞瘤中的低炎症。
除了邻域定义外,我们还评估了它们的诊断潜力。在星形细胞瘤中,AC样富集标志着良好预后,而MES1样的普遍存在则界定了高风险患者。有鉴于此,我们探究了邻域是否在常规H&E中具有组织病理学对应关系。用组织病理学基础模型提取的形态嵌入恢复了反映微龛组成的簇,表明邻域可从H&E形态学推断并纳入诊断工作流程。
总之,这些发现通过将肿瘤状态与其TME联系起来,阐明了胶质瘤微解剖异质性。通过捕捉空间依赖的程序,我们的工作为将空间结构整合到生物学理解、诊断和风险分层中提供了一个框架。
查看英文原文 English abstract
Adult gliomas exhibit substantial molecular and pathological variation. Prior single-cell studies have characterized intratumoral heterogeneity; in glioblastoma, tumor cells adopt lineage-associated programs-such as oligodendrocyte- and neuro- progenitor (OPC, NPC), astrocyte (AC) and mesenchymal (MES) like states. However, how these states recur across other gliomas remains unclear. Given their shared environment, defining conserved versus entity-specific tumor characteristics is essential for understanding glioma heterogeneity.
Here, we analyzed 310 tumor cores from 284 patients spanning oligodendroglioma, astrocytoma, glioblastoma, and ependymoma, using single-cell spatial transcriptomics with a 344-gene panel (10x Xenium). This approach yielded a dataset of 2.8 million cells, including 18 tumor microenvironment (TME) cell types. To further probe local interactions, we profiled a validation cohort of astrocytomas using a 5,096-genes panel and multiplexed immunofluorescence (57 proteins).
Our data revealed 9 recurrent tumor states across gliomas, organized into neighborhoods shaped by local cellular interactions. These formed structured layers, with OPC-/NPC-like tumors near cortical interfaces and AC-like regions forming a continuum with MES1-gliosis. Neighborhoods were largely subtype-specific suggesting that tissue organization and not cell composition alone, underlies glioma heterogeneity. Consistently, methylation classification-central to subtype definition in gliomas-stratified the cohort into 13 classes with distinct neighborhood profiles, including characteristic architectures in RTK1, RTK2, and MES glioblastomas.
Neighborhoods also showed distinct TME variation: P2RY12⁺ microglia were enriched in AC-like and MES1-gliosis regions, while CD163⁺ myeloid cells concentrated in MES1-gliosis and MES2-hypoxia niches. These immune patterns corresponded to neighborhood-specific inflammatory programs and at the entity level to myeloid-dominated inflammation in ependymoma and low inflammation in oligodendroglioma.
Beyond neighborhood definition, we evaluated their diagnostic potential. In astrocytoma, AC-like enrichment marked favorable prognosis, whereas MES1-like prevalence defined high-risk patients. Given this, we asked whether neighborhoods show histopathological correlates in routine H&E. Morphology embeddings extracted with histopathology foundation models recovered clusters mirroring niche composition, indicating that neighborhoods can be inferred from H&E morphology and incorporated into diagnostic workflows.
Collectively, these findings link glioma microanatomy heterogeneity by connecting tumor states to their TME. By capturing spatially dependent programs, our work provides a framework for integrating spatial architecture into biological understanding, diagnosis, and risk stratification.
利益披露 Disclosure
A. Mathioudaki, None..
Z. Seferbekova, None..
S. Rutz, None..
M. Ritter, None..
D. Calafato, None..
G. Rukhovich, None..
F. Hinz, None..
P. Mahlknecht, None..
F. Ippen, None..
E. Popova, None..
S. Schinkewitsch, None..
N. Koeberer, None..
N. Wilhelm, None..
P. Sant, None..
J. Malm, None..
S. Dietrich, None..
C. Herold-Mende, None..
N. Etminan, None..
A. Wick, None..
S. Krieg, None..
M. Platten, None..
A. von Deimling, None..
F. Sahm, None..
A. Suwala, None..
M. Gerstung, None.